BioStem Technologies, Inc. (OTC: BSEM) Announces Issuance of FDA Drug Establishment Registration Number and FDA Labeler Code ...
June 02 2016 - 9:30AM
Marketwired
BioStem Technologies, Inc. (OTC: BSEM) Announces Issuance of FDA
Drug Establishment Registration Number and FDA Labeler Code to
Wholly Owned Subsidiary BioStem Pharmaceuticals, Inc.
OAKLAND PARK, FL-(Marketwired - Jun 2, 2016) - BioStem
Technologies, Inc. ("BioStem" or the "Company") (OTC PINK: BSEM)
announced today that the FDA has accepted and issued BioStem
Pharmaceuticals, Inc., a wholly owned subsidiary of the Company,
its FDA Drug Establishment Registration Number and Labeler Code for
Manufacturing and Repackaging of pharmaceutical products.
BioStem Pharmaceuticals is a pharmaceutical distribution and
manufacturing company that is focused on the redistribution of
Active Pharmaceutical Ingredients as well as development and
approval of New Drug Applications. The FDA Establishment
Registration and Labeler Code allows BioStem Pharmaceuticals to
manufacture and distribute pharmaceuticals products in the United
States.
The Office of Compliance, Immediate Office oversees the
electronic Drug Registration and Listing System, a key component of
the Food and Drug Administration's ability to monitor drug safety.
Section 510 of the Federal Food, Drug, and Cosmetic Act requires
firms that manufacture, prepare, propagate, compound, or process
drugs in the U.S. or that are offered for import into the U.S. to
register with the FDA. These domestic and foreign firms must at the
time of registration, list all drugs manufactured, prepared,
propagated, compounded, or processed for commercial distribution in
the U.S.
Joe Esposito, President of BioStem Pharmaceuticals, went on to
say, "We are very excited to have this process completed. This now
gives us the ability to move forward with the development and
manufacturing of strategically chosen products that have been
mapped out in our business plan."
About BioStem Technologies, Inc. (OTC PINK: BSEM): BioStem
Technologies (OTC PINK: BSEM) is in the business of regenerative
medicine and antiaging strategies throughout the United States,
Europe, and Mexico. The Company's mission is to conquer the effects
of biological aging (and related acute disease), and its strategy
is to discover, develop, produce, and deliver the most effective
stem cell and wellness products in the world. The Company is
comprised of a diverse group of scientists, physicians, and
industry visionaries who are creating innovative products for
helping customers live their best, feel their best, and be their
best. The company operates four strategic business units - BioStem
Cell Therapy, BioStem Wellness, BioStem Pharmaceuticals, and
BioStem International - providing a diversified line of products
and services that include: clinical stem cell therapy, stem cell
R&D, state-of-the-art laboratory services, pharmaceuticals,
nutraceuticals, cosmeceuticals, API Repackaging, and medical
tourism.
Forward-Looking Statements Except for statements of historical
fact, the matters discussed in this press release are forward
looking and made pursuant to the Safe Harbor provisions of the
Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or
strategies and are generally preceded by words such as "future,"
"plan" or "planned," "expects," believe" or "projected." These
forward-looking statements reflect numerous assumptions and involve
a variety of risks and uncertainties, many of which are beyond the
company's control that may cause actual results to differ
materially from stated expectations. These risk factors include,
among others, limited operating history, difficulty in developing,
exploiting and protecting proprietary technologies, intense
competition and additional risks factors as discussed in reports
filed by the company with OTC Markets.
Contact Information
Contact: BioStem Technologies, Inc. Phone: 954-380-8342 Website:
http://www.biostemtech.com Email: info@biostemtech.com Twitter:
@BioStemTech Facebook: BioStem Technologies
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From Apr 2023 to Apr 2024